US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE GRENOBLE ALPES, CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE on Sept. 29 for "Serological marker for the latent form of toxoplasmosis" (French Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,748,112, issued on Sept. 29, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris), UNIVERSITE GRENOBLE ALPES (Saint Martin d'Heres, France) and CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE (La Tronche, France).

"Serological marker for the latent form of toxoplasmosis" was invented by Celine Dard (La Tronche, France), Mohamed-Ali Hakimi (La Tronche, France), Herve Pelloux (La Tronche, France), Mariee-Pierre Brenier-Pinchart (La Tronche, France) and Christopher Swale (La Tronche, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "In the present invention...